Publications by authors named "Michael Ezekowitz"

Claim this Profile
R
Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.
Linda S Johnson, Alexander P Benz, Ashkan Shoamanesh, John W Eikelboom, Michael Ezekowitz

J Am Heart Assoc· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ATHERO-AF Study: A Need to Optimize AF Management in an Environment of Medical Advancement.
Michael D Ezekowitz, Ibrahim Alameh, Mohammed Kamareddine

JACC Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.
Linda S Johnson, Yuxuan Jiang, Judy Luu, Isabelle C Van Gelder, Clare Atzema, Michael D Ezekowitz

Eur Heart J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials.
Sachin J Shah, Carl van Walraven, Sun Young Jeon, John Boscardin, F D Richard Hobbs, Michael D Ezekowitz

Circ Cardiovasc Qual Outcomes· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registries.
Toon Wei Lim, Alan John Camm, Saverio Virdone, Daniel E Singer, Jean P Bassand, Michael Ezekowitz

Clin Cardiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Filling an Important Knowledge Gap: The DOAC Score.
Michael D Ezekowitz, Mohammed Kamareddine

Circulation· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overestimation of anticoagulant benefit in patients with atrial fibrillation and low life expectancy: evidence from 12 randomized trials.
Sachin J Shah, Carl van Walraven, Sun Young Jeon, W John Boscardin, Fd Richard Hobbs, Michael Ezekowitz

medRxiv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral Anticoagulant.
Roy Taoutel, Michael D Ezekowitz, Usman A Chaudhry, Carly Weber, Dana Hassan

Int J Cardiol Heart Vasc· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation.
Matthew A Carlisle, Peter Shrader, Marat Fudim, Karen S Pieper, Rosalia G Blanco, Michael D Ezekowitz

Heart Rhythm O2· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
Tymon Pol, Ziad Hijazi, Johan Lindbäck, Jonas Oldgren, John H Alexander, Michael D Ezekowitz

Cardiovasc Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Interactions Affecting Oral Anticoagulant Use.
Philip L Mar, Rakesh Gopinathannair, Brooke E Gengler, Mina K Chung, Arturo Perez, Michael D Ezekowitz

Circ Arrhythm Electrophysiol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Interactions Affecting Antiarrhythmic Drug Use.
Philip L Mar, Piotr Horbal, Mina K Chung, Jonathan W Dukes, Michael Ezekowitz

Circ Arrhythm Electrophysiol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic.
Hans H Liu, Michael D Ezekowitz, Michele Columbo, Oneib Khan, Jack Martin

J Interv Card Electrophysiol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease.
Alexander P Benz, Jeff S Healey, Ashley Chin, Patrick Commerford, Tamara Marsden, Michael D Ezekowitz

Cardiovasc Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Anthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, John Eikelboom, Robert P Giugliano, Michael Ezekowitz

Circulation· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of sinus rhythm 6 weeks after cardioversion of atrial fibrillation: a pre-planned post hoc analysis of the X-VeRT trial.
Riccardo Cappato, Michael D Ezekowitz, Stefan H Hohnloser, Isabelle Ling Meng, Melanie Wosnitza

Europace· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future is now: our experience starting a remote clinical trial during the beginning of the COVID-19 pandemic.
Hans H Liu, Michael D Ezekowitz, Michele Columbo, Oneib Khan, Jack Martin

Trials· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LVS-HARMED Risk Score for Incident Heart Failure in Patients With Atrial Fibrillation Who Present to the Emergency Department: Data from a World-Wide Registry.
Linda S B Johnson, Jonas Oldgren, Tyler W Barrett, Candace D McNaughton, Jorge A Wong, Michael Ezekowitz

J Am Heart Assoc· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Low-Dose Direct Acting Anticoagulant and Warfarin in patients Aged ≥80 years With Atrial Fibrillation.
Usman A Chaudhry, Michael D Ezekowitz, Edward J Gracely, Winson T George, Catrina M Wolfe

Am J Cardiol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial).
Dominic Millenaar, Helmut Schumacher, Martina Brueckmann, John W Eikelboom, Michael Ezekowitz

Am J Cardiol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.
Tymon Pol, Ziad Hijazi, Johan Lindbäck, John H Alexander, M Cecilia Bahit, Michael D Ezekowitz

Open Heart· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
Ziad Hijazi, Lars Wallentin, Johan Lindbäck, John H Alexander, Stuart J Connolly, Michael D Ezekowitz

J Am Heart Assoc· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
Lars Wallentin, Johan Lindbäck, Niclas Eriksson, Ziad Hijazi, John W Eikelboom, Michael D Ezekowitz

Eur Heart J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study).
Andreas Goette, Gregory Y H Lip, James Jin, Hein Heidbuchel, Aron-Ariel Cohen, Michael Ezekowitz

Am J Cardiol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.
Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, John H Alexander, Marco Alings, Michael D Ezekowitz

JAMA Netw Open· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis